The treat-to-target revolution hits gout

A panel of rheumatologists and other specialists has developed the first international treat-to-target recommendations for gout.

Writing in the Annals of the Rheumatic Diseases, the authors say gout is “an ideal disease in which to apply a T2T approach”.

But they say a key problem for this approach is that the threshold between severe and mild disease states in gout has never been